Skip to content
Trial Eligibility
Menu

Genesis Electrical Impedance Tomography (EIT): A Preliminary Study

NCT03797183

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study is to evaluate the Genesis Electrical Impedance Tomography (EIT) imaging system for use in pediatric respiratory disease populations including neuromuscular and bronchopulmonary dysplasia, as well as in age and height matched controls. The EIT does not use radiation, and is read through electrodes.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Premature Infant
  • Chronic Respiratory Disease
  • Neuromuscular Diseases
  • Healthy
  • Bronchopulmonary Dysplasia
  • Pulmonary Vein Stenoses

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
14 days to 40 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Colorado, Denver
Last updated on ClinicalTrials.gov
November 13, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Colorado · 1

  • Children's Hospital Colorado · Aurora, CO

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.